Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for BRRDF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 -44.37M
March 31, 2026 4.112M
December 31, 2025 -13.59M
September 30, 2025 -16.36M
June 30, 2025 -23.12M
March 31, 2025 7.587M
December 31, 2024 -7.010M
September 30, 2024 -25.22M
June 30, 2024 -22.31M
March 31, 2024 -7.033M
December 31, 2023 -34.52M
September 30, 2023 -2.385M
June 30, 2023 1.400M
March 31, 2023 -3.025M
December 31, 2022 -4.416M
September 30, 2022 -14.11M
June 30, 2022 -16.31M
March 31, 2022 15.60M
December 31, 2021 -19.47M
September 30, 2021 -26.36M
June 30, 2021 -34.99M
March 31, 2021 -16.80M
December 31, 2020 -1.109M
September 30, 2020 -13.14M
June 30, 2020 -17.39M
Date Value
March 31, 2020 -8.100M
December 31, 2019 -9.879M
September 30, 2019 -12.75M
June 30, 2019 -7.515M
March 31, 2019 13.87M
December 31, 2018 -1.184M
September 30, 2018 5.705M
June 30, 2018 0.4984M
March 31, 2018 7.527M
December 31, 2017 17.02M
September 30, 2017 6.911M
June 30, 2017 -9.399M
March 31, 2017 -2.016M
December 31, 2016 -26.59M
September 30, 2016 0.3604M
June 30, 2016 -17.69M
March 31, 2016 0.1157M
December 31, 2015 -8.088M
September 30, 2015 -7.661M
June 30, 2015 1.419M
March 31, 2015 -7.860M
December 31, 2014 -6.391M
September 30, 2014 -4.322M
June 30, 2014 -20.38M
March 31, 2014 -2.134M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Elkem ASA 109.33M
Albemarle Corp. -80.05M
Balchem Corp. -44.83M
Celanese Corp. -546.00M
Core Molding Technologies, Inc. 0.00